FDA inspection
MS Pharma Inc.: FDA inspection ending Mar 15, 2019
FDA inspection 1082763 · Voluntary Action Indicated (VAI) · Laval
Key facts
| Inspection ID | 1082763 |
|---|---|
| Firm | MS Pharma Inc. |
| FEI number | 3014216410 |
| Address | 230 Rue Bernard-Belleau |
| City | Laval |
| Country | Canada |
| Fiscal year | 2019 |
| Inspection end date | Mar 15, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data